Intellia Therapeutics (NTLA) Asset Utilization Ratio (2016 - 2026)

Intellia Therapeutics (NTLA) has 11 years of Asset Utilization Ratio data on file, last reported at 0.08 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 97.25% year-over-year to 0.08 in Q1 2026; TTM through Mar 2026 was 0.08, a 97.25% increase from a year earlier, with the FY2025 full-year figure at 0.07, up 43.31% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.08, up from 0.08 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for NTLA reached as high as 0.08 in Q1 2026 and fell as low as 0.03 in Q4 2023.
• Historically, Asset Utilization Ratio has averaged 0.05 across 5 years, with a median of 0.04 in 2023.
• Across the five-year window, Asset Utilization Ratio plunged 59.0% in 2022 and soared 97.25% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.04 in 2022, then dropped by 28.75% to 0.03 in 2023, then surged by 71.69% to 0.05 in 2024, then jumped by 56.41% to 0.08 in 2025, then increased by 7.82% to 0.08 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.08 in Q1 2026, 0.08 in Q4 2025, and 0.06 in Q3 2025.